AIMC Topic: Pathologists

Clear Filters Showing 1 to 10 of 129 articles

Pathologist-like explainable AI for interpretable Gleason grading in prostate cancer.

Nature communications
The aggressiveness of prostate cancer is primarily assessed from histopathological data using the Gleason scoring system. Conventional artificial intelligence (AI) approaches can predict Gleason scores, but often lack explainability, which may limit ...

Exploring the risks of over-reliance on AI in diagnostic pathology. What lessons can be learned to support the training of young pathologists?

PloS one
The integration of Artificial Intelligence (AI) algorithms into pathology practice presents both opportunities and challenges. Although it can improve accuracy and inter-rater reliability, it is not infallible and can produce erroneous diagnoses, hen...

Deep learning quantifies pathologists' visual patterns for whole slide image diagnosis.

Nature communications
Based on the expertise of pathologists, the pixelwise manual annotation has provided substantial support for training deep learning models of whole slide images (WSI)-assisted diagnostic. However, the collection of pixelwise annotation demands massiv...

A Comprehensive AI-Based Approach in Classifying Breast Lesions: Focusing on Improving Pathologists' Accuracy and Efficiency.

Clinical breast cancer
BACKGROUND: Accurate classification of breast lesions is essential for effective clinical decision-making and patient management. In this study, we evaluated an artificial intelligence (AI) solution to classify whole slide images (WSIs) of breast les...

Comparative performance of PD-L1 scoring by pathologists and AI algorithms.

Histopathology
AIM: This study evaluates the comparative effectiveness of pathologists versus artificial intelligence (AI) algorithms in scoring PD-L1 expression in non-small cell lung carcinoma (NSCLC). Immune-checkpoint inhibitors have revolutionized NSCLC treatm...

A Perspective on Artificial Intelligence for Molecular Pathologists.

The Journal of molecular diagnostics : JMD
The widespread adoption of next-generation sequencing technology in molecular pathology has enabled us to interrogate the genome as never before. The huge quantities of data generated by sequencing, the enormous complexity of human and microbial gene...

Artificial intelligence for diagnosis and predictive biomarkers in Non-Small cell lung cancer Patients: New promises but also new hurdles for the pathologist.

Lung cancer (Amsterdam, Netherlands)
The rapid development of artificial intelligence (AI) based tools in pathology laboratories has brought forward unlimited opportunities for pathologists. Promising AI applications used for accomplishing diagnostic, prognostic and predictive tasks are...

Predicting cancer content in tiles of lung squamous cell carcinoma tumours with validation against pathologist labels.

Computers in biology and medicine
BACKGROUND: A growing body of research is using deep learning to explore the relationship between treatment biomarkers for lung cancer patients and cancer tissue morphology on digitized whole slide images (WSIs) of tumour resections. However, these W...

The Promise of AI for Image-Driven Medicine: Qualitative Interview Study of Radiologists' and Pathologists' Perspectives.

JMIR human factors
BACKGROUND: Image-driven specialisms such as radiology and pathology are at the forefront of medical artificial intelligence (AI) innovation. Many believe that AI will lead to significant shifts in professional roles, so it is vital to investigate ho...

Making Pathologists Ready for the New Artificial Intelligence Era: Changes in Required Competencies.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
In recent years, there has been an increasing interest in developing and using artificial intelligence (AI) models in pathology. Although pathologists generally have a positive attitude toward AI, they report a lack of knowledge and skills regarding ...